Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 44.99% institutional investors, 8.04% insiders, and 46.97% retail investors. Vanguard group is the largest institutional shareholder, holding 4.17% of RLMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 44.99% | 8.04% | 46.97% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
| Idea | Psychedelic Stocks List | 21.83% | 11.18% | 66.99% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.26M | 4.17% | $3.77M |
| Deep track capital, lp | 1.23M | 4.10% | $3.70M |
| Vestal point capital, lp | 1.20M | 3.98% | $3.60M |
| Acadian asset management | 1.19M | 3.96% | $3.58M |
| Franklin resources | 1.01M | 3.36% | $3.04M |
| Parsons capital management inc/ri | 975.95K | 3.24% | $2.93M |
| Palo alto investors lp | 732.40K | 2.43% | $2.20M |
| Opaleye management | 600.00K | 1.99% | $1.80M |
| Blackrock | 573.31K | 1.90% | $1.72M |
| Jpmorgan chase | 352.62K | 1.17% | $1.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Opaleye management | 600.00K | 0.41% | $1.80M |
| Vestal point capital, lp | 1.20M | 0.27% | $3.60M |
| Palo alto investors lp | 732.40K | 0.25% | $2.20M |
| Parsons capital management inc/ri | 975.95K | 0.20% | $2.93M |
| Apricus wealth | 78.86K | 0.17% | $236.59K |
| Deep track capital, lp | 1.23M | 0.11% | $3.70M |
| Tang capital management | 237.87K | 0.07% | $713.62K |
| Advisorshares investments | 90.03K | 0.05% | $276.39K |
| Spotlight asset group | 20.00K | 0.04% | $60.00K |
| Pegasus asset management | 26.96K | 0.03% | $80.87K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 1.01M | 0.00% | 382.41K |
| Tang capital management | 237.87K | 0.07% | 237.49K |
| Jpmorgan chase | 352.62K | 0.00% | 176.64K |
| Renaissance | 88.78K | 0.00% | 53.77K |
| Advisorshares investments | 90.03K | 0.05% | 19.98K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 64.36K | 0.00% | -277.09K |
| Opaleye management | 600.00K | 0.41% | -159.00K |
| Goldman sachs group | - | - | -118.24K |
| Silverarc capital management | - | - | -99.38K |
| Morgan stanley | 46.18K | - | -74.34K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Beacon pointe advisors | 10.09K | 0.00% | 10.09K | $30.27K |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Smartleaf asset management | -35.00 |
| Qube research | -56.00 |
| Macquarie group | -856.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 83 | -15.31% | 13,556,139 | -5.26% | 44 | 1.99% | 21 | -48.78% | 31 | 24.00% |
| Mar 31, 2024 | 98 | 11.36% | 14,308,498 | 5.06% | 47 | 2.32% | 41 | 2.50% | 25 | 25.00% |
| Dec 31, 2023 | 88 | -2.22% | 13,619,817 | -9.16% | 45 | 1.82% | 40 | 90.48% | 20 | -50.00% |
| Sep 30, 2023 | 90 | -6.25% | 14,992,668 | -6.88% | 49 | 1.74% | 21 | -51.16% | 40 | 25.00% |
| Jun 30, 2023 | 96 | 3.23% | 16,100,099 | -9.48% | 53 | 1.53% | 43 | 26.47% | 32 | -5.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 851.92K | 2.82% | - |
| Franklin Biotechnology Discv A(acc)USD | 845.70K | 2.80% | - |
| Franklin Biotechnology Discovery A | 456.40K | 1.51% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 353.63K | 1.17% | - |
| Horizons Psychedelic Stock ETF | 227.04K | 0.75% | -36.13K |
| Fidelity Extended Market Index | 161.21K | 0.53% | 15.95K |
| Bridgeway Ultra-Small Company | 100.18K | 0.33% | -14.70K |
| AdvisorShares Psychedelics ETF | 93.08K | 0.31% | - |
| Federated Hermes MDT Small Cap Growth IS | 87.42K | 0.29% | -8.59K |
| Federated Hermes MDT SCG Institutional | 87.42K | 0.29% | -8.59K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $153.71K |
| Sep 09, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $150.62K |
| Sep 10, 2024 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $90.79K |
| Sep 09, 2024 | CASAMENTO CHARLES J | - | Buy | $33.28K |
| Sep 11, 2024 | Shenouda Maged | Chief Financial Officer | Buy | $71.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 9 | - |
| 2023 Q4 | - | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools